Picture of Aptevo Therapeutics logo

APVO — Aptevo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aptevo Therapeutics - Fuad El-Hibri, Chairman Of Board, Notified Co Of His Retirement, Resignation As A Director Of Co, Effective April 1, 2022

Jan 21 (Reuters) - Aptevo Therapeutics Inc  APVO.O :
    * APTEVO THERAPEUTICS - FUAD EL-HIBRI, CHAIRMAN OF BOARD,
NOTIFIED
CO OF HIS RETIREMENT, RESIGNATION AS A DIRECTOR OF CO, EFFECTIVE
APRIL 1, 2022
    * APTEVO THERAPEUTICS - BOARD APPOINTED JOHN NIEDERHUBER,
M.D. AS
CHAIRMAN OF THE BOARD EFFECTIVE APRIL 1, 2022
    * APTEVO THERAPEUTICS - EFFECTIVE APRIL 1, 2022, THE SIZE OF
THE
COMPANY’S BOARD OF DIRECTORS WILL BE REDUCED FROM SEVEN TO SIX
DIRECTORS - SEC FILING

Source text: [ID: https://bit.ly/3Ky54qM]
Further company coverage:  APVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aptevo Therapeutics

See all news